Curcumin analog exhibited anti-inflammatory activity through inhibiting ERK/JNK and NF-κB signaling pathway

Chinese Traditional and Herbal Drugs

Volumn 47, Issue 16, 2016, Pages 2871-2876

  Jiang, Cheng Xi ^a,b   Wu, Liang ^a   Wu, Jie ^b   Yu, Zhi Min ^c   Li, Xiao Kun ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b Jiuhua Mountain Research Institute of Polygonatum in Chizhou City   (China)

^c Wenzhou Xinte Medicine Co Ltd   (China)

Author keywords

Curcumin; Curcumin analogs; Inflammatory cytokines; Interleukin 6; NF B; Tumor necrosis factor

Indexed keywords

ANTIINFLAMMATORY AGENT; CURCUMIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 16; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CYTOKINE PRODUCTION; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG STABILITY; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; IN VITRO STUDY; MACROPHAGE ACTIVATION; MTT ASSAY; PERITONEUM MACROPHAGE; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84995377802     PISSN: 02532670     EISSN: None     Source Type: Journal    
DOI: 10.7501/j.issn.0253-2670.2016.16.016     Document Type: Article

References (21)

1. Bone R C, Balk R A, Cerra F B, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis [J]. Chest, 1992, 101(6): 1644-1655.
2. Annane D, Bellissant E, Cavaillon J M. Septic shock [J]. Lancet, 2005, 365(9453): 63-78.
3. Dellinger R P, Levy M M, Carlet J M, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008 [J]. Intens Care Med, 2008, 34(1): 17-60.
4. Calixto J B, Campos M M, Otuki M F, et al. Anti-inflammatory compounds of plant origin. Part II. modulation of pro-inflammatory cytokines, chemokines and adhesion molecules [J]. Planta Med, 2004, 70(2): 93-103.
5. Maciel M C, Fialho E M, Guerra R N, et al. Tityus serrulatus scorpion venom improves survival and lung inflammation in lethal sepsis induced by CLP in mice [J]. Toxicon: Offic J Int Soc Toxinol, 2014, 89: 1-8.
6. Saraux A, Benichou J, Guillevin L, et al. Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-alpha antagonists in France? The CORPUS cohort study [J]. Clin Exper Rheumatol, 2015, 33(5): 602-610.
7. Ghaffar O, Lavigne F, Kamil A, et al. Interleukin-6 expression in chronic sinusitis: colocalization of gene transcripts to eosinophils, macrophages, T lymphocytes, and mast cells [J]. Otolaryngol-head Neck Surg, 1998, 118(4): 504-511.
8. Hu J, Zhang Y, Dong L, et al. Design, synthesis, and biological evaluation of novel quinazoline derivatives as anti-inflammatory agents against lipopolysaccharide- induced acute lung injury in rats [J]. Chem Biol Drug Des, 2015, 85(6): 672-684.
9. Grogan G. Emergent mechanistic diversity of enzyme- catalysed beta-diketone cleavage [J]. Biochem J, 2005, 388(3): 721-730.
10. Zhang Y, Jiang X, Peng K, et al. Discovery and evaluation of novel anti-inflammatory derivatives of natural bioactive curcumin [J]. Drug Des Dev Ther, 2014, 8: 2161-2171.
11. Liang G, Yang S, Zhou H, et al. Synthesis, crystal structure and anti-inflammatory properties of curcumin analogues [J]. Eur J Med Chem, 2009, 44(2): 915-919.
12. Patwardhan R S, Checker R, Sharma D, et al. Dimethoxycurcumin, a metabolically stable analogue of curcumin, exhibits anti-inflammatory activities in murine and human lymphocytes [J]. Biochem Pharmacol, 2011, 82(6): 642-657.
13. Weng Q, Fu L, Chen G, et al. Design, synthesis, and anticancer evaluation of long-chain alkoxylated mono- carbonyl analogues of curcumin [J]. Eur J Med Chem, 2015, 103: 44-55.
14. Byun E B, Sung N Y, Park J N, et al. Gamma-irradiated resveratrol negatively regulates LPS-induced MAPK and NF-kappaB signaling through TLR4 in macrophages [J]. Int Immunopharmacol, 2015, 25(2): 249-259.
15. Guimaraes M R, Leite F R, Spolidorio L C, et al. Curcumin abrogates LPS-induced pro-inflammatory cytokines in RAW 264.7 macrophages. Evidence for novel mechanisms involving SOCS-1, -3 and p38 MAPK [J]. Arch Oral Biol, 2013, 58(10): 1309-1317.
16. Zhao C, Liu Z, Liang G. Promising curcumin-based drug design: mono-carbonyl analogues of curcumin (MACs) [J]. Curr Pharm Des, 2013, 19(11): 2114-2135.
17. Selvam C, Jachak S M, Thilagavathi R, et al. Design, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and anti-inflammatory agents [J]. Bioorg Med Chem Lett, 2005, 15(7): 1793-1797.
18. Raetz C R, Whitfield C. Lipopolysaccharide endotoxins [J]. Ann Rev Biochem, 2002, 71: 635-700.
19. Lee H S, Jung K K, Cho J Y, et al. Neuroprotective effect of curcumin is mainly mediated by blockade of microglial cell activation [J]. Die Pharmazie, 2007, 62(12): 937-942.
20. Baldwin A S. The NF-kappa B and I kappa B proteins: new discoveries and insights [J]. Ann Rev Immunol, 1996, 14: 649-683.
21. Poylin V, Fareed M U, O'Neal P, et al. The NF-kappaB inhibitor curcumin blocks sepsis-induced muscle proteolysis [J]. Mediat Inflamm, 2008, 2008: 317851.